Procter & Gamble (NYSE:PG) Price Target Raised to $190.00 at Wells Fargo & Company

Procter & Gamble (NYSE:PG) had its price target hoisted by Wells Fargo & Company from $188.00 to $190.00 in a report issued on Friday,Benzinga reports. They currently have an overweight rating on the stock.

A number of other analysts have also recently issued reports on PG. DA Davidson reiterated a “neutral” rating and set a $160.00 target price on shares of Procter & Gamble in a report on Wednesday. DZ Bank raised Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 price target on the stock in a research report on Thursday, August 29th. Wolfe Research raised Procter & Gamble to a “strong-buy” rating in a research report on Friday, August 23rd. JPMorgan Chase & Co. boosted their price target on Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a research report on Thursday, September 19th. Finally, Barclays lowered Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price target on the stock. in a research report on Monday, September 30th. Nine analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $178.00.

Procter & Gamble Stock Up 2.0 %

PG opened at $176.26 on Friday. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The stock has a market capitalization of $415.10 billion, a price-to-earnings ratio of 30.39, a price-to-earnings-growth ratio of 3.74 and a beta of 0.42. The business has a 50-day moving average of $170.04 and a two-hundred day moving average of $168.62. Procter & Gamble has a 12 month low of $142.50 and a 12 month high of $177.94.

Procter & Gamble (NYSE:PG) last issued its earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The business had revenue of $21.74 billion during the quarter, compared to analysts’ expectations of $21.99 billion. During the same quarter in the previous year, the business earned $1.83 EPS. The company’s revenue for the quarter was down .6% on a year-over-year basis. On average, research analysts expect that Procter & Gamble will post 6.94 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were issued a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a yield of 2.28%. The ex-dividend date was Friday, October 18th. Procter & Gamble’s payout ratio is currently 69.48%.

Insider Activity at Procter & Gamble

In other Procter & Gamble news, CEO Jon R. Moeller sold 87,979 shares of the firm’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $170.40, for a total transaction of $14,991,621.60. Following the completion of the sale, the chief executive officer now directly owns 300,777 shares in the company, valued at approximately $51,252,400.80. This trade represents a 22.63 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Balaji Purushothaman sold 12,800 shares of the firm’s stock in a transaction dated Thursday, October 24th. The stock was sold at an average price of $168.99, for a total value of $2,163,072.00. Following the sale, the insider now owns 11,566 shares of the company’s stock, valued at $1,954,538.34. The trade was a 52.53 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 160,693 shares of company stock worth $27,311,345 in the last quarter. 0.18% of the stock is owned by company insiders.

Institutional Investors Weigh In On Procter & Gamble

A number of institutional investors have recently bought and sold shares of the business. Itau Unibanco Holding S.A. acquired a new stake in shares of Procter & Gamble during the 2nd quarter valued at about $28,000. Fairway Wealth LLC acquired a new stake in shares of Procter & Gamble during the 2nd quarter valued at about $29,000. RPg Family Wealth Advisory LLC bought a new position in shares of Procter & Gamble in the 3rd quarter valued at approximately $33,000. POM Investment Strategies LLC bought a new position in shares of Procter & Gamble in the 2nd quarter valued at approximately $34,000. Finally, Quest Partners LLC bought a new position in shares of Procter & Gamble in the 2nd quarter valued at approximately $36,000. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Procter & Gamble Company Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.